Sutro Biopharma (STRO) Interest & Investment Income (2017 - 2025)
Sutro Biopharma recorded quarterly Interest & Investment Income of $12.3 million in Q4 2025, up 513.44% quarter-over-quarter from $2.0 million in Q3 2025, and up 253.28% year-over-year from $3.5 million in Q4 2024.
Sutro Biopharma's Interest & Investment Income history runs 9 years deep, the most recent figure standing at $12.3 million for Q4 2025.
- In Q4 2025, Interest & Investment Income rose 253.28% year-over-year to $12.3 million; the TTM figure through Dec 2025 stood at $16.5 million (up 330.91% YoY), while the FY2025 annual figure was $9.3 million, down 50.38% from the prior year.
- Interest & Investment Income came in at $12.3 million for Q4 2025 at Sutro Biopharma, up from $2.0 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $12.3 million in Q4 2025 to a low of -$8.0 million in Q4 2024.
- A 5-year average of $10600.0 and a median of -$625500.0 in 2022 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income plunged 2657.8% in 2022 and soared 277.98% in 2024, its largest moves.
- Sutro Biopharma's Interest & Investment Income stood at -$3.6 million in 2021, then jumped by 158.82% to $2.1 million in 2022, then jumped by 114.19% to $4.6 million in 2023, then sank by 276.39% to -$8.0 million in 2024, then jumped by 253.28% to $12.3 million in 2025.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $12.3 million, $2.0 million, and -$1.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Sutro Biopharma | 242.87 Mn | 242.87 Mn | - | 12.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.32 Mn |
| Sep 30, 2025 | 2.01 Mn |
| Jun 30, 2025 | -1.04 Mn |
| Mar 31, 2025 | 3.19 Mn |
| Dec 31, 2024 | -8.04 Mn |
| Sep 30, 2024 | 4.88 Mn |
| Jun 30, 2024 | -1.76 Mn |
| Mar 31, 2024 | -2.21 Mn |
| Dec 31, 2023 | 4.56 Mn |
| Sep 30, 2023 | -2.74 Mn |
| Jun 30, 2023 | -2.92 Mn |
| Mar 31, 2023 | -2.99 Mn |
| Dec 31, 2022 | 2.13 Mn |
| Sep 30, 2022 | -2.79 Mn |
| Jun 30, 2022 | -594,000.00 |
| Mar 31, 2022 | -657,000.00 |
| Dec 31, 2021 | -3.62 Mn |
| Sep 30, 2021 | 109,000.00 |
| Jun 30, 2021 | 175,000.00 |
| Mar 31, 2021 | 197,000.00 |
| Dec 31, 2020 | -5.29 Mn |
| Sep 30, 2020 | 295,000.00 |
| Jun 30, 2020 | 384,000.00 |
| Mar 31, 2020 | 641,000.00 |
| Dec 31, 2019 | 810,000.00 |
| Sep 30, 2019 | 964,000.00 |
| Jun 30, 2019 | 1.12 Mn |
| Mar 31, 2019 | -1.16 Mn |
| Dec 31, 2018 | 1.13 Mn |
| Sep 30, 2018 | 403,000.00 |
| Jun 30, 2018 | 40,000.00 |
| Mar 31, 2018 | 40,000.00 |
| Dec 31, 2017 | 81,000.00 |
| Sep 30, 2017 | 62,000.00 |